"Cases of coronavirus in the state are declining and the demand and consumption of medical oxygen, Remdesivir injections and Favipiravir ta...

If successful, Hetero will become the first Indian drug maker to introduce favipiravir in injection form which is hitherto available only i...

"The launch of 'Favivir 800/200' is aimed at enhancing patients' adherence to treatment regimen by reducing the number of pills they are re...

The company had received approval from the Drugs Controller General of India (DCGI) to manufacture Favipiravir to treat patients with mild ...

Indian generic drug maker Dr Reddy's Laboratories on Wednesday announced the launch of antiviral drug Avigan (favipiravir) tablets, current...

The higher strength will improve compliance for patients by effectively reducing the number of tablets required per day, Glenmark said in a...

BDR pharma has received an approval from the DCGI to manufacture Favipiravir to treat mild to moderate patients with COVID-19 symptoms. The...

Favipiravir has received authorisation from the Drug Controller General of India (DCGI) for emergency use, Lupin said in a regulatory filin...

Favipiravir, along with another antiviral, remdesivir, has emerged as one of the most sought-after drugs at hospitals fighting COVID-19 in ...

Over the next few weeks, close to 10 drug companies including Abbott, Lupin, Micro Labs, Mcleods Pharma, Cipla, Strides Pharma and Dr Reddy...

However, the experts were not convinced and decided not to put it in the revised treatment protocol,” a person aware of the matter told ET ...

The company hopes that the availability of an effective treatment such as FabiFlu will considerably help assuage this pressure, and offer p...

“Under an accelerated approval process at the Central Drugs Standard Control Organisation (CDSCO), the Subject Expert Committee (SEC) has r...

"This drug was already being used in Japan for influenza. They have been using it in COVID-19 patients also. Even China was using it and Ru...

After rallying 27 per cent in the previous session, the scrip traded 5.24 per cent lower at Rs 492.

The firm launched antiviral drug Favipiravir for the treatment of Covid-19 patients.

Strides Pharma Science Ltd on Wednesday said it has developed and commercialised Favipiravir antiviral tablets and stressed that the drug h...